v3.26.3
Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Income Statement [Abstract]        
Federal grants $ 2,181,632 $ 493,104 $ 4,306,945 $ 3,184,314
Operating expenses:        
Research and development 3,175,848 2,954,909 8,994,480 6,763,866
General and administrative 1,594,722 1,279,290 4,040,022 3,879,569
Acquired in-process research and development 79,907,223 79,907,223
Total operating expenses 84,677,793 4,234,199 92,941,725 10,643,435
Loss from operations (82,496,161) (3,741,095) (88,634,780) (7,459,121)
Other income (expense):        
Change in fair value of liability classified warrants 998 10,061
Interest expense, net (3,147) (6,369) (7,390) (13,385)
Foreign exchange gain (loss), net 316,713 316,713
Other income and expense, net 69,012 17,338 84,584 54,227
Total other income (expense), net 382,578 11,967 393,907 50,903
Net loss (82,113,583) (3,729,128) (88,240,873) (7,408,218)
Net loss attributable to noncontrolling interests (166) (166)
Deemed dividend related to settlement of equity instruments 204,539 204,539
Net loss attributable to common stockholders (82,318,122) (3,729,128) (88,445,246) (7,408,052)
Other comprehensive income (loss):        
Foreign currency translation adjustments, net of tax (236,991) (236,991)
Total comprehensive income (loss), net $ (82,555,113) $ (3,729,128) $ (88,682,237) $ (7,408,052)
Net loss per basic and diluted share:        
Net loss per share attributable to common stockholders, basic $ (4.52) $ (1.29) $ (6.95) $ (3.42)
Net loss per share attributable to common stockholders, diluted $ (4.52) $ (1.29) $ (6.95) $ (3.42)
Weighted average common shares outstanding, basic 18,193,164 2,886,059 12,730,983 2,168,247
Weighted average common shares outstanding, diluted 18,193,164 2,886,059 12,730,983 2,168,247

Source